Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A banner announces NIH’s terminology transition, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.
    Difference
    0.6%
    Check dated 2026-10-26T13:56:54.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The website’s footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T13:55:14.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer site revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T14:50:51.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    An updated revision entry labeled v3.7.0 was added to the record history, replacing the previous v3.6.6 and indicating the page was updated.
    Difference
    0.1%
    Check dated 2026-09-21T19:58:43.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page history shows a new revision tag, updating from v3.6.5 to v3.6.6. This signals a new version of the record metadata rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-31T17:33:06.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The Study Record History now shows the latest revision as v3.6.5, replacing the previous v3.6.4. This reflects a page revision update at the system level rather than a change to trial details.
    Difference
    0.1%
    Check dated 2026-08-10T10:26:55.000Z thumbnail image

Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.